Intercept Pharmaceuticals Morristown , NJ 07963
Posted 3 weeks ago
POSITION SUMMARY:
As Intercept continues to build its position as the leader in rare and serious liver disease, we are seeking a Director, US HCP Marketing. This position will be responsible for shaping the strategic development and tactical execution for HCPs including professional promotion and Promotional Medical education. This person will be accountable to meet key strategic imperatives of the brand and contributing to revenue performance in the U.S to meet and exceed goals. Tactical execution will include development of marketing collateral, peer-to-peer content, and training resources. Responsibilities include management of core agencies including advertising agency (agency of record) and promotional medical education agency.
The position requires a highly motivated individual who can work independently, think strategically, and collaborate cross-functionally to accomplish complex deliverables on tight timelines and to perform all responsibilities in accordance with company policies, procedures and training.
The incumbent will work closely with multiple functional groups across the organization, including but not limited to Field Sales, Field Medical, Market Research, Medical Affairs, Sales Training, Regulatory and Legal.
The role is based in our Morristown, NJ Headquarters with flexibility for remote work 2-3 days per week.
JOB RESPONSIBILITIES:
Requirements
QUALIFICATIONS:
REQUIRED KNOWLEDGE AND ABILITIES:
Benefits
ABOUT INTERCEPT:
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). Intercept’s lead product, obeticholic acid (OCA), is a first-in-class farnesoid X receptor (FXR) agonist marketed under the brand name OCALIVA® in the U.S. for the treatment of patients with primary biliary cholangitis (PBC), a rare autoimmune liver disease. OCALIVA® was the first medication to be approved for PBC in over twenty years, and sales continue to grow more than five years after its initial approval in 2016.
People at Intercept are passionate about patients. You’ll see our patient photos lining our walls and hear their stories in town halls. We’re equally passionate about our team and ensuring each member feels included and has the opportunity to reach their potential. We recognize the power of a diverse, equitable and inclusive (DEI) work force, and how it enriches the professional lives of our team members. Diversity, Equity, and Inclusion drives innovation and connects us to the patients and communities we serve.
For more information, please visit www.interceptpharma.com.
COMPENSATION & BENEFITS:
The anticipated salary range for this position is $215,000 to $240,000. This represents the anticipated low and high end of the salary range for this position. Actual salaries may vary based on various factors including, but not limited to, experience, skillset, and performance.
The salary range listed is just one component of our total compensation package. Intercept also provides a competitive suite of benefits, including:
EEO Statement
Employment decisions at the Company are made without unlawful regard to race, color, religion, creed, national origin, alienage or citizenship status, sex (including gender, pregnancy, childbirth or medical conditions related to pregnancy or childbirth), gender identity or expression, sexual orientation, national origin, ethnicity, age, physical or mental disability, legally protected genetic information, marital or partnership status, sexual and reproductive health decisions, military or veteran status, or any other status protected by applicable federal, state, or local law. This organization participates in E-Verify (E-Verify's Right to Work guidance can be found here: https://www.e-verify.gov/sites/default/files/everify/posters/IER_RighttoWorkPoster.pdf).
#LI-JJ1
Intercept Pharmaceuticals